John Matson

2.2k total citations
17 papers, 1.5k citations indexed

About

John Matson is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, John Matson has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Hematology. Recurrent topics in John Matson's work include DNA and Nucleic Acid Chemistry (5 papers), RNA Interference and Gene Delivery (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). John Matson is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), RNA Interference and Gene Delivery (4 papers) and Neurogenetic and Muscular Disorders Research (3 papers). John Matson collaborates with scholars based in United States, United Kingdom and France. John Matson's co-authors include Richard S. Geary, Rosie Z. Yu, Arthur A. Levin, Frank Rigo, Gene Hung, Yimin Hua, C. Frank Bennett, Adrian R. Krainer, Scott P. Henry and Lisa M. Stanek and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Analytical Biochemistry.

In The Last Decade

John Matson

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Matson United States 16 1.2k 470 191 138 111 17 1.5k
Nicolas J. Niederländer United States 13 565 0.5× 123 0.3× 200 1.0× 58 0.4× 33 0.3× 19 853
Takehisa Kitazawa Japan 17 687 0.6× 382 0.8× 58 0.3× 47 0.3× 90 0.8× 52 1.8k
Huilei Xu United States 14 1.3k 1.1× 162 0.3× 73 0.4× 195 1.4× 42 0.4× 21 1.8k
Andrew J. Leger United States 14 827 0.7× 268 0.6× 101 0.5× 75 0.5× 323 2.9× 16 1.6k
Jörg Bungert United States 29 2.0k 1.7× 278 0.6× 51 0.3× 347 2.5× 34 0.3× 66 2.3k
Ida Casella Italy 15 961 0.8× 170 0.4× 62 0.3× 77 0.6× 176 1.6× 24 1.4k
Manami Ohtaka Japan 20 1.3k 1.1× 73 0.2× 203 1.1× 275 2.0× 68 0.6× 45 1.6k
Metka Ravnik‐Glavač Slovenia 21 1.0k 0.9× 149 0.3× 79 0.4× 110 0.8× 63 0.6× 50 1.5k
Tatsuo Morimura Japan 20 611 0.5× 213 0.5× 91 0.5× 68 0.5× 49 0.4× 46 1.2k
Joseph N. McLaughlin United States 14 568 0.5× 132 0.3× 43 0.2× 40 0.3× 137 1.2× 21 991

Countries citing papers authored by John Matson

Since Specialization
Citations

This map shows the geographic impact of John Matson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Matson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Matson more than expected).

Fields of papers citing papers by John Matson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Matson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Matson. The network helps show where John Matson may publish in the future.

Co-authorship network of co-authors of John Matson

This figure shows the co-authorship network connecting the top 25 collaborators of John Matson. A scholar is included among the top collaborators of John Matson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Matson. John Matson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Jafar‐Nejad, Paymaan, Berit Powers, Armand Soriano, et al.. (2020). The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration. Nucleic Acids Research. 49(2). 657–673. 62 indexed citations
2.
Post, Noah, Rosie Z. Yu, Sarah Greenlee, et al.. (2019). Metabolism and Disposition of Volanesorsen, a 2′-O-(2 methoxyethyl) Antisense Oligonucleotide, Across Species. Drug Metabolism and Disposition. 47(10). 1164–1173. 44 indexed citations
3.
Ochaba, Joseph, Andrew F. Powers, Sarah Greenlee, et al.. (2019). A novel and translational role for autophagy in antisense oligonucleotide trafficking and activity. Nucleic Acids Research. 47(21). 11284–11303. 16 indexed citations
4.
Kim, Tae‐Won, Jeffery A. Engelhardt, Noah Post, et al.. (2018). Comparison of the Class Effects of Antisense Oligonucleotides in CByB6F1-Tg(HRAS)2Jic and CD-1 Mice. Toxicologic Pathology. 47(1). 82–92.
5.
Ross, Jacob A., Hichem Tasfaout, Christine Kretz, et al.. (2018). Reducing dynamin 2 (DNM2) rescues DNM2 -related dominant centronuclear myopathy. Proceedings of the National Academy of Sciences. 115(43). 11066–11071. 48 indexed citations
6.
Shen, Lijiang, Gene Hung, Rie Kikkawa, et al.. (2016). Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2′- O -Methoxyethyl Modified Antisense Oligonucleotide. Nucleic Acid Therapeutics. 26(4). 236–249. 18 indexed citations
7.
Ackermann, Elizabeth J., Shuling Guo, Merrill D. Benson, et al.. (2016). Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides. Amyloid. 23(3). 148–157. 114 indexed citations
8.
Rigo, Frank, Seung Chun, Daniel A. Norris, et al.. (2014). Pharmacology of a Central Nervous System Delivered 2′-O-Methoxyethyl–Modified Survival of Motor Neuron Splicing Oligonucleotide in Mice and Nonhuman Primates. Journal of Pharmacology and Experimental Therapeutics. 350(1). 46–55. 213 indexed citations
9.
Passini, Marco A., Jie Bu, Amy M. Richards, et al.. (2011). Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy. Science Translational Medicine. 3(72). 72ra18–72ra18. 415 indexed citations
10.
Geary, Richard S., John Matson, Megan Pearce, et al.. (2009). Effect of dose and plasma concentration on liver uptake and pharmacologic activity of a 2′-methoxyethyl modified chimeric antisense oligonucleotide targeting PTEN. Biochemical Pharmacology. 78(3). 284–291. 66 indexed citations
11.
Yu, Rosie Z., Kristina M. Lemonidis, Mark J. Graham, et al.. (2008). Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100. Biochemical Pharmacology. 77(5). 910–919. 96 indexed citations
12.
Miner, Philip B., Richard S. Geary, John Matson, et al.. (2006). Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 23(10). 1427–1434. 39 indexed citations
13.
Geary, Richard S., Rosie Z. Yu, Tanya Watanabe, et al.. (2003). PHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIES. Drug Metabolism and Disposition. 31(11). 1419–1428. 141 indexed citations
14.
Yu, Rosie Z., Richard S. Geary, David Monteith, et al.. (2003). Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys. Journal of Pharmaceutical Sciences. 93(1). 48–59. 83 indexed citations
15.
Yu, Rosie Z., Richard S. Geary, Janet M. Leeds, et al.. (2001). Comparison of pharmacokinetics and tissue disposition of an antisense phosphorothioate oligonucleotide targeting human Ha‐ras mRNA in mouse and monkey. Journal of Pharmaceutical Sciences. 90(2). 182–193. 45 indexed citations
16.
Geary, Richard S., John Matson, & Arthur A. Levin. (1999). A Nonradioisotope Biomedical Assay for Intact Oligonucleotide and Its Chain-Shortened Metabolites Used for Determination of Exposure and Elimination Half-Life of Antisense Drugs in Tissue. Analytical Biochemistry. 274(2). 241–248. 26 indexed citations
17.
Yu, Rosie Z., Richard S. Geary, Janet M. Leeds, et al.. (1999). Pharmacokinetics and Tissue Disposition in Monkeys of an Antisense Oligonucleotide Inhibitor of Ha-Ras Encapsulated in Stealth Liposomes. Pharmaceutical Research. 16(8). 1309–1315. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas J. Niederländer Breakdown of academic impact, for papers by Takehisa Kitazawa Breakdown of academic impact, for papers by Huilei Xu Breakdown of academic impact, for papers by Andrew J. Leger Breakdown of academic impact, for papers by Jörg Bungert Breakdown of academic impact, for papers by Ida Casella Breakdown of academic impact, for papers by Manami Ohtaka Breakdown of academic impact, for papers by Metka Ravnik‐Glavač Breakdown of academic impact, for papers by Tatsuo Morimura Breakdown of academic impact, for papers by Joseph N. McLaughlin
Rankless by CCL
2026